Who invested in BEAT BioTherapeutics?
BEAT BioTherapeutics's investors include The W Fund and CET Capital Partners.
United States · Seed startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow BEAT BioTherapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 7 Nov 2026
$2.5Mraised across 1 round since 2013, from 1 source
Reported by businesswire.comSEC filing: $2.4M sold, first sale Apr 2013
BEAT BioTherapeutics filed one raise, $2.4M in all. Filings say how much was sold and to how many investors; they never name the investors.
From the SEC filings it signed: 2 on the team.
On the board, as filediCraig TallJim Leggett
BEAT BioTherapeutics's investors include The W Fund and CET Capital Partners.
BEAT BioTherapeutics has raised $2.5M across 1 round since 2013.
BEAT BioTherapeutics's most recent round was a Seed of $2.5M in Apr 2013.
Its most recent round, $2.5M in Apr 2013, is also its largest on record.
BEAT BioTherapeutics's first round on record, in Apr 2013, was backed by The W Fund and CET Capital Partners.
BEAT BioTherapeutics's latest named round is a Seed, in Apr 2013.
BEAT BioTherapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.